Lack of observed interference by therapeutic monoclonal antibodies in select commonly utilized immunoassays
CONCLUSION: These findings demonstrate no detectable tmab interference for the assessed immunoassays using spiked preparations of the tmabs in residual human sera. The findings are limited to the tmabs and immunoassays studied here.PMID:37972806 | DOI:10.1016/j.clinbiochem.2023.110685
Source: Clinical Biochemistry - Category: Biochemistry Authors: Kornelia D Galior Paula M Ladwig Melissa R Snyder Alicia Algeciras-Schimnich Joshua A Bornhorst Darci R Block Nikola A Baumann Maria Alice V Willrich Source Type: research
More News: Biochemistry | Cancer | Cancer & Oncology | Hormones | Humira | Laboratory Medicine | Merck | Remicade | Study | Thyroid | Thyroid Cancer | Yervoy